Pain and heart rate variability in neonates receiving dexmedetomidine

期刊论文
发表日期：

2024年7月20日

查看全文

Catarina Sevivas,
Ruth Ibáñez,
Melissa Fontalvo,
María Luz Couce,
Marta Camprubí-Camprubí

摘要

Introduction

Neonates in a NICU experience pain. Based on the cardiovascular and nociceptive systems link, a Newborn Infant Parasympathetic Evaluation (NIPE) monitor was designed to assess pain. The use of α₂-agonists as analgesic-sedative drugs has increased in neonates. Given their effect on the autonomic system, we hypothesized that their use may alter NIPE’s measurement capacity.

Methods

Data were prospectively collected. The included patients were evaluated using combined pain assessment systems.

Results

Sixteen newborns requiring sedoanalgesia underwent a total of 84 pain assessments. A good correlation was found between the NIPE-index and the COMFORT-neo and the crSO2 (cerebral regional oxygen saturation). No correlation was found in premature infants. By sedation group, the correlation remained in those receiving α_2-agonist.

Conclusion

NIPE is a reliable tool for pain assessment. Further studies in premature infants are needed. The use of α_2-agonist does not alter the measuring capacity of NIPE. The correlation between NIPE-index and crSO2 was also demonstrated.